Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study-Reference-Cited by-同舟云学术

Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: Results of a phase 2 randomized study

Published:2006 Issue:9 Volume:12 Page:1381-1389
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Schiano Thomas D.,Charlton Michael,Younossi Zobair,Galun Eithan,Pruett Timothy,Tur-Kaspa Ran,Eren Rachel,Dagan Shlomo,Graham Neil,Williams Paulette V.,Andrews John

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference31 articles.

1. Predictors of patient and graft survival following liver transplantation for hepatitis C

2. Management of hepatitis C virus infection in the setting of liver transplantation

3. How should we treat recurrent hepatitis C after liver transplantation?

4. Antiviral treatment of recurrent hepatitis C after liver transplantation: The need for a multifaceted approach

5. Hepatitis B and Hepatitis C Viruses in Liver Transplantation

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver retransplantation in the modern concept of treatment of its terminal pathology (literature review);Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH);2023-10-08

2. Viral Escape Mechanisms in Hepatitis C and the Clinical Consequences of Persistent Infection;The Liver;2020-01-24

3. Antibody Therapy for the Control of Viral Diseases: An Update;Current Pharmaceutical Biotechnology;2019-10-28

4. 5-Oxo-1-[(2,3,6,7-tetramethoxy-9-phenanthrenyl)methyl]-L-proline Inhibits Hepatitis C Virus Entry;Scientific Reports;2019-05-13

5. Viral hepatitis: Guidelines by the American Society of Transplantation Infectious Disease Community of Practice;Clinical Transplantation;2019-04-14